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Influence of sodium hyaluronate on iNOS expression in
synovium and NO content in synovial fluid of rabbits
with traumatic osteoarthritis
QIU Bo邱波*, LIU Shi-qing刘世清 and PENG Hao彭昊
Objective:  To observe the influence of intra-articular
injection of sodium hyaluronate (SH) on the expression of
inducible nitric oxide synthase (iNOS) in the synovium and
nitric oxide (NO) content in synovial fluid of rabbits with
traumatic osteoarthritis (OA).
Methods:  Sixteen white rabbits underwent unilateral
anterior cruciate ligament transection and were randomly
divided into 2 groups 5 weeks after the operation. Rabbits
in the experimental group received intra-articular injection
of 0.3 ml of 1% SH, once a week for 5 weeks. Animals in the
control group were treated under the same conditions us-
ing physiological saline. All the animals were sacrificed at
the 10th week after surgery. The mRNA expression of iNOS
in the synovium was analyzed using reverse transcription-
polymerase chain reaction. The content of NO in the syn-
ovial fluid was assayed.
Results:  The level of iNOS expression of the
synovium in the experimental group was lower than that in
control group (0.47 ± 0.09 vs. 0.65 ± 0.12, t =3.45, P<0.01).
Compared with control group, the content of NO decreased
significantly in synovial fluid of SH injection group (134.11
µmol/L ± 12.47 µmol/L vs. 152.17 µmol/L ± 15.69 µmol/L,
t =2.55, P<0.05).
Conclusions:  SH significantly decreases the content
of NO in the synovial fluid of rabbits with traumatic OA. SH
may exert the effect on synovial fluid NO level as a result of
the suppression of iNOS expression in the synovium. It
may be one of the mechanisms of the therapeutic effect of
SH on early traumatic OA.
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Osteoarthritis (OA) is one of the most commonarthropathy. Traumatic OA resulted from theinjury or operation of the joints is commonly
seen. It is recognized that nitric oxide (NO) generated
enzymatically by nitric oxide synthase (NOS) plays a
vital role during the development of OA. Intra-articular
injection of sodium hyaluronate (SH) has been reported
to have a positive effect on the treatment of OA.1-3
However, the mechanisms of such beneficial effect of
SH on OA have not yet been fully established. To fur-
ther clarify the effect of SH on OA, we investigated the
mechanisms of SH on traumatic OA in this study.  The
expression of inducible NOS (iNOS) in the synovium
and NO content in synovial fluid were assessed in ex-
perimentally induced traumatic OA rabbits with or with-
out intra-articular injection of SH.
METHODS
Experimental animals
Sixteen white rabbits weighing 2.4-2.8 kg were used
in this study. All animals provided by the Experimental
Animal Centre of Medical College of Wuhan University
were anesthetized intravenously with ketamine hydro-
chloride (1.0 mg/kg). The animals received unilateral
anterior cruciate ligament transection (ACLT). Rabbits
were divided into 2 groups randomly 5 weeks after
operation. Each group had 8 rabbits. Experimental group
received 0.3 ml of 1% SH by intra-articular injection,
once a week for 5 weeks. The control group was treated
under the same condition using physiological saline.
After surgery, the animals were housed individually in
stainless-steel cages without any immobilization and
maintained under the same environmental condition.
All animals were killed 10 weeks after surgery.
Reverse transcription-polymerase chain reaction
(RT-PCR) assay
Primers used in this study were synthesized by
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Shanghai Sangon Biological Engineering Technology
and Service Company. Primers used for rabbit glycer-
aldehydes-3-phosphate dehydrogenase (GAPDH) and
iNOS were as follows. GAPDH (444bp)4 sense, 5’- ATC
ACT GCC ACC CAG AAG AC -3’antisense,  5’- ATG
AGG TCC ACC ACC CTG TT -3’. iNOS (262bp)5 sense,
5’-CGC CCT TCC GCA GTT CT-3’; antisense, 5’-TCC AGG
AGG ACA TGC AGC AC-3’.
The synovium closed to the position of degenera-
tive cartilage was harvested. The synovium tissue was
powdered in liquid nitrogen by hand milling. Total RNA
extraction was performed according to the instruction
of Trizol Reagent (Invitrogen Co.USA). Reverse tran-
scription and polymerase chain reaction were under-
taken according to the literature described previously.6
Amplification consisted of 45 seconds at 95°C, 45 sec-
onds at 57°C (GAPDH) and 65°C (iNOS) for annealing,
45 sec at 72°C for extension. Thirty cycles and 35
cycles of amplification were performed for GAPDH and
iNOS respectively. Electrophoresis of the PCR prod-
ucts on a 1.5% agarose gel with 0.5 pg/ml of ethidium
bromide was performed to evaluate amplification and
size of generated fragments. French VL analysis sys-
tem was used to scan the RT-PCR agarose gel. GAPDH
was used to verify that equal amount of RNA was added
to the reaction. The band intensities of gene expres-
sion were reported as the ratio of iNOS to GAPDH on
the expression quantities.
Assay of NO content in the joint fluid
NO is chemically active and can be converted into
nitrite (NO2
­) and nitrate (NO3
­) quickly in vivo. So the
total concentration of  NO2
­ and NO3
­ can exactly indi-
cate the level of NO.
The synovial fluids were aspirated from the knee
joints and stored at -80°C until analysis. The synovial
fluid of the knee joint was collected and then analyzed
according to the instruction of the NO detection kit
(Nanjing Jiancheng Bioengineering Institute, China) for
NO2
­ and NO3
­ determination. The method used nitrate
reductase to determine the NO level of the synovial fluids.
Statistical analysis
The data were expressed as x ± s. Using a com-
mercial software SPSS10.0, statistical analysis was
performed by Student’s t test and statistical significance
was defined as P<0.05.
RESULTS
In the synovium, iNOS mRNA expression of the
experimental group (0.47 ± 0.09) was significantly lower
than that of the control group (0.65 ± 0.12) (t=3.45,
P=0.004), (Figs.1-2).
A significant decrease of NO level in synovial fluid
was detected in SH treated group compared with con-
trol group (134.11 ± 12.47) µmol/L vs. (152.17 ± 15.69)
µmol/L, t=2.55, P=0.023).
DISCUSSION
NO is an inorganic, gaseous free radical. NO is pro-
duced in large amounts by chondrocytes and
synoviocytes. Chondrocytes and synovium cells are
known to produce a large amount of NO when they are
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Fig.1.  An electrophoregram of GAPDH. M:PCR marker, from
downside to upside, the size is 1543bp,994bp, 697bp, 515bp,
377bp and 237bp, respectively. 1: the synovium of experimental
group. 2: the synovium of control group. 3: negative control.
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 Fig.2.  An electrophoregram of iNOS shows the effect of SH on
iNOS mRNA expression.
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stimulated by proinflammatory cytokines. In contrast
to normal cartilage, OA cartilage sponstaneously pro-
duces NO. A high-level of NO has been detected in the
synovial joint fluid and serum of the patients with OA.
Increasing evidence indicates that NO may contribute
to the pathophysiology of OA. It has been demonstrated
that high local concentration of NO may exert detri-
mental effects on chondrocyte functions including the
inhibition of collagen and proteoglycan synthesis, the
activity of metalloproteinases, the decreased expres-
sion of interleukin-1 (IL-1) receptor antagonist, the inhi-
bition of chondrocyte proliferation, the induction of
apoptosis, and so on. NO is involved in the pathogen-
esis of OA. Therefore, the role of NO located in the
joints on pathogenesis of OA have attracted the atten-
tion of researchers.
None of the synovium samples examined from nor-
mal joints demonstrated detectable amounts of iNOS.7
A high-level of iNOS expression in cartilages of OA has
been detected. Large amounts of NO can be produced
by iNOS catalysis. Strong iNOS expression is observed
in the synovial lining layer and subsynovium.8 NO pro-
duced by the constitutive isoform of nitric oxide syn-
thase (cNOS) is a key regulator of homeostasis,
whereas the generation of NO by the iNOS plays an
important role in inflammation, host defense response,
and tissue repair. Cytokines such as IL-1 and tumor
necrosis factor (TNF), which induce iNOS production
in chondrocytes and synovium, have been implicated
in the destruction of cartilage in OA. iNOS is calcium
independent and, once activated, produces large
amounts of NO. In the present study, iNOS was ob-
served to be expressed strongly in the synovium and
NO in the joint fluid was detected at high levels in the
control group. The results indicate that NO is one of
the mechanisms of degeneration of cartilage and plays
an important role in the progression of OA. These find-
ings make us thinking that NO in synovial fluid is a
potent mediator in cartilage damage in OA.
Intra-articular injection of SH has been used in OA
treatment to prevent degeneration of articular cartilage.
Several studies have reported that SH has beneficial
effects on cartilage during OA development. Exogenous
SH has been used as a lubricative agent, but it is also
known to delay the degradation of cartilage by inhibit-
ing the release of proteoglycan from articular cartilage.
SH has anti-inflammatory effects and down-regulates
the expression of MMP-3 and IL-1 beta in the synovium.
Guarda et al9 have observed that injection of SH caused
significant improvement in the main clinical symptoms.
Among patients who received SH injection, those who
reached a good outcome showed the lowest basal lev-
els of NO. Kobayashi et al.10 have reported that the
treatment of OA with intra-articular injection of SH led
to a significant reduction of NO level in the joint fluid.10
Takahashi et al.11 reported that SH exerted the inhibi-
tory effect on NO level in the synovial fluid as a result of
the suppression of NO production in the menisci and
synovium in patients with OA.11 SH does not show defi-
nite effect on iNOS expression in cartilage of OA.6 Our
results showed that the level of iNOS expression in the
synovia among rabbits treated with SH intra-articular
injection was significantly lower than that in control group
and SH had inhibitory effect on NO production of the
synovium. We also observed that the level of NO de-
creased significantly in synovial fluid of SH injection
group. It might be related to the down-regulation effect
of SH on iNOS of the synovium.
The present study provides the evidence that intra-
articular injection of SH significantly decreases the NO
level in synovial joint fluid in the ACLT rabbit OA model.
Exogenous SH treatment has an inhibiting effect on
iNOS expression in the synivium. We conclude that
low NO levels in synovial fluid are related to the sup-
pressive effects of SH on iNOS expression of the
synovium. It may be one of the mechanisms of the thera-
peutic effect of SH on traumatic OA.
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